Evoked resonant neural activity in subthalamic local field potentials reflects basal ganglia network dynamics.

Adaptive DBS Deep brain stimulation Evoked resonant neural activity Local field potentials Parkinson's disease Subthalamic nucleus

Journal

Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169

Informations de publication

Date de publication:
03 2023
Historique:
received: 21 11 2022
revised: 11 01 2023
accepted: 23 01 2023
pubmed: 28 1 2023
medline: 16 2 2023
entrez: 27 1 2023
Statut: ppublish

Résumé

Evoked resonant neural activity (ERNA) is induced by subthalamic deep brain stimulation (DBS) and was recently suggested as a marker of lead placement and contact selection in Parkinson's disease. Yet, its underlying mechanisms and how it is modulated by stimulation parameters are unclear. Here, we recorded local field potentials from 27 Parkinson's disease patients, while leads were externalised to scrutinise the ERNA. First, we show that ERNA in the time series waveform and spectrogram likely represent the same activity, which was contested before. Second, our results show that the ERNA has fast and slow dynamics during stimulation, consistent with the synaptic failure hypothesis. Third, we show that ERNA parameters are modulated by different DBS frequencies, intensities, medication states and stimulation modes (continuous DBS vs. adaptive DBS). These results suggest the ERNA might prove useful as a predictor of the best DBS frequency and lowest effective intensity in addition to contact selection. Changes with levodopa and DBS mode suggest that the ERNA may indicate the state of the cortico-basal ganglia circuit making it a putative biomarker to track clinical state in adaptive DBS.

Identifiants

pubmed: 36706929
pii: S0969-9961(23)00033-5
doi: 10.1016/j.nbd.2023.106019
pmc: PMC7614125
mid: EMS163206
pii:
doi:

Substances chimiques

Levodopa 46627O600J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106019

Subventions

Organisme : Medical Research Council
ID : MR/P012272/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V00655X/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no competing interests.

Auteurs

Christoph Wiest (C)

Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Shenghong He (S)

Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Benoit Duchet (B)

Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Alek Pogosyan (A)

Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Moaad Benjaber (M)

Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Timothy Denison (T)

Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Harutomo Hasegawa (H)

Department of Neurosurgery, King's College Hospital, Denmark Hill, London, UK.

Keyoumars Ashkan (K)

Department of Neurosurgery, King's College Hospital, Denmark Hill, London, UK.

Fahd Baig (F)

Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Neurosciences Research Centre, Molecular and Clinical Sciences Institute, St. George's, University of London, London, UK.

Ilaria Bertaina (I)

Neurosciences Research Centre, Molecular and Clinical Sciences Institute, St. George's, University of London, London, UK; Neurology Department, Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.

Francesca Morgante (F)

Neurosciences Research Centre, Molecular and Clinical Sciences Institute, St. George's, University of London, London, UK.

Erlick A Pereira (EA)

Neurosciences Research Centre, Molecular and Clinical Sciences Institute, St. George's, University of London, London, UK.

Flavie Torrecillos (F)

Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.

Huiling Tan (H)

Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Electronic address: huiling.tan@ndcn.ox.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH